A new review in Medical Oncology examines marine microbial arginase as a stable enzyme platform for arginine deprivation ...
Oncolytics Biotech Inc. announced updated data from Cohort 4 of its Phase 1/2 GOBLET study evaluating pelareorep in combination with atezolizumab in patients with second-line or later squamous cell ...
Scrotal squamous cell carcinoma (SCC) incidence increased by more than 5% annually from 2000 to 2023, with non-Hispanic Black ...
Everyday Health on MSN
Your advanced skin cancer care team
Learn how a multidisciplinary team of specialists collaborates to provide comprehensive care for advanced skin cancer, ...
Oncolytics Biotech Inc. (Nasdaq: ONCY) released updated data from Cohort 4 of its Phase 1/2 GOBLET study, showing a median duration of response of approximately 15 months for pelareorep combined ...
SCC is a common skin cancer, more aggressive than basal cell carcinoma, with potential to metastasize. Long-term UV exposure is a primary cause, with SCC often appearing on sun-exposed areas.
Genmab A/S announced updated results from a Phase 2 trial evaluating petosemtamab, an investigational IgG1-bispecific antibody targeting the epidermal growth factor receptor (EGFR) and leucine-rich ...
Prioritize HPV16-targeted vaccines, checkpoint inhibitor combinations and biomarker-led patient selection to overcome resistance and capture underserved HNSCC segments.Dublin, Sept. 30, 2026 (GLOBE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results